Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.19.3
Summary of Significant Accounting Policies (Details Narrative)
1 Months Ended 3 Months Ended 12 Months Ended
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Mar. 31, 2017
USD ($)
Dec. 31, 2018
USD ($)
Segment
Dec. 31, 2017
USD ($)
Estimated contractual allowances       $ 63,000 $ 7,000
Total uncompensated care as a percentage of gross revenues       0.11 0.18
Bad debts       $ 9,400,000 $ 1,500,000
Allowance for adjustment of revenue       73,500,000 20,900,000
Impairment charge       173,799
Derivative liability     $ 56,000,000    
Reversal of interest expense     41,000,000  
Discount on convertible debenture $ 6,247,469 $ 12,127,634   6,247,469 $ 12,127,634
Deemed dividend, down round feature     53,300,000 $ 231,800,000  
Deemed dividend     $ 51,000,000    
Number of operating segment | Segment       2  
Additional Paid in Capital [Member]          
Discount on convertible debenture 15,000,000     $ 15,000,000  
Jamestown Regional Medical Center [Member]          
Impairment charge $ 200,000        
Genomas, Inc [Member]          
Goodwill impairment charge   $ 1,000,000